Tuesday, September 27 @ 1:00PM ET
#FDALRFChat is a special Blood Abnormal cell growth that cannot be controlled by the body's natural defenses. Cancerous cells can grow and eventually form tumors. Awareness Month chat featuring R. Angelo de Claro, MD and Yvette Kasamon, MD from the Division of Hematology Products, Office of Hematology and Oncology Products; and the Office of Health and Constituent Affairs at the U.S. Food and Drug Administration. The Twitter chat provided an opportunity for the lymphoma community to ask the FDA and LRF questions and learn about patient access to clinical trials and lymphoma therapies, the FDA Patient Representative Program and how the FDA approaches the development of breakthrough therapies in lymphoma.